New Test for Broken-Heart Syndrome Offers Insights into the Mysterious Disease

Takotsubo syndrome, also known as broken-heart syndrome, is a mysterious condition that often follows acute emotional stressors, such as the loss of a loved one. Diagnosis typically involves invasive procedures like catheterization to detect arterial blockages and differentiate it from a traditional heart attack. However, a new study could offer a non-invasive alternative for detecting this condition.

Researchers from the University of Zurich examined blood samples from over 3,600 patients, leading to the identification of five biomarkers that accurately predicted broken-heart syndrome in nearly 90 percent of cases. The BioTAK score, derived from these biomarkers, including peptidylglycine α-amidating monooxygenase (PAM) and soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1), provides insights into the biological processes that distinguish this syndrome from a classic heart attack.

While the new test shows great promise in guiding diagnostic procedures and avoiding unnecessary invasive tests, it won’t replace traditional catheterization entirely.